US FDA warns of serious risks with psoriasis drug Raptiva®

被引：0

|

作者：

不详

机构：

来源：

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2009年 / 7卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：393 / 394

页数：2

相关论文

共 50 条

[21] US FDA warns that Ocaliva is being incorrectly dosed
[J]. Reactions Weekly, 2017, 1672 (1) : 9 - 9
[22] US FDA warns of dangers of Miracle Mineral Solution
[J]. Reactions Weekly, 2019, 1767 (1) : 4 - 4
[23] FDA warns propylhexedrine abuse or misuse may cause serious AEs
[J]. Reactions Weekly, 2021, 1849 (1) : 9 - 9
[24] FDA warns of risks associated with the use of antipsychotic medications in pregnancy
不详
[J]. FORMULARY, 2011, 46 (04) : 147 - 147
[25] FDA warns Pfizer on failure to report drug problems
Barnett, AA
[J]. LANCET, 1996, 347 (9014): : 1546 - 1546
[26] US FDA warns of hidden drug ingredients in Dr Ergin's SugarMD Advanced Glucose Support
[J]. Reactions Weekly, 2023, 1983 (1) : 6 - 6
[27] US FDA Commissioner warns of "devastating" impact of funding cuts
不详
[J]. FUTURE MEDICINAL CHEMISTRY, 2011, 3 (06) : 644 - 644
[28] US FDA warns that stopping Gilenya can worsen MS
[J]. Reactions Weekly, 2018, 1730 (1) : 5 - 5
[29] Brazilian diet pills may be harmful, warns US FDA
[J]. Reactions Weekly, 2006, 1085 (1) : 3 - 3
[30] US FDA warns of injection-site reactions with naltrexone
[J]. Reactions Weekly, 2008, 1216 (1) : 5 - 5

← 1 2 3 4 5 →